Nasdaq-listed Tharimmune (THAR) has raised about $540 million in a private placement led by DRW and Liberty City Ventures, as the biotech firm pivots toward a digital asset treasury (DAT) strategy centered on canton coin (CC), the company said in a press release Monday. THAR is up roughly 30% on the announcement. The thinly-traded canton coin, the utility token powering the Canton Network, a blockchain designed for institutional finance, is lower by 4%. The round also drew participation from a wide range ...